IR-MED Inc

OTCQB:IRMEUnited States

IR-Med, Inc. is a development-stage medical device company. The Company develops non-invasive devices for various medical indications, by detecting and measuring various biomarkers and molecules in the blood and in human tissue in real-time. The Company’s devices allow healthcare professionals to detect and measure different molecules in the blood and in human tissue in real-time without any invasive procedures. Its initial product candidates are in various stages of development. It is focused on two principal medical devices: PressureSafe and Nobiotics. PressureSafe is a handheld optical monitoring device that is being developed to support the early detection of pressure injuries (PI) to the skin and underlying tissue, primarily caused by prolonged pressure associated with bed confinement. Nobiotics is an otoscope, which is designed to support physicians with an immediate indication as to whether mid-ear infection (Otitis Media) is of a bacterial origin.

Contact Information

Headquarters

C/O ABOUDI LEGAL GROUP PLLC 745 5TH AVE, SUITE 500NEW YORK, NY, United States 10151

Phone

646-768-4285

Fax

916-720-0663

Executives

Executive Chairman of the Board

Oded Bashan

Interim Chief Executive Officer, Chief Technology Officer, Director, Interim Chief Executive Officer - IR-Med LTD

Aharon Klein

Chief Financial Officer

Sharon Levkoviz

Vice President - Business Development, Director

Yoram Drucker

Chief Development Officer

Aharon Binur